pharmacopsychiatry
130595
EN
DE
Home
Produkte
Zeitschriften
Bücher
Buchreihen
Service
Service für Bibliotheken
Hilfe
Kontakt
Portal
Pharmacopsychiatry
Volltextsuche
Volltextsuche
Autorensuche
Titelsuche
DOI-Suche
Metadatensuche
Zeitschrift
Über diese Zeitschrift
Herausgeber
Informationen zur DFG-Nationallizenz
Impressum
X
Autor*innen
Autorenhinweise
Manuskript einreichen
Abonnement
Ihr Abonnement: Kontakt & Information
Lizenzen: Kontaktpartner Institutionen
AGNP
Offizielles Organ der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
nicht eingeloggt
Login
Benutzername oder E-Mail-Adresse:
Passwort:
Zugangsdaten vergessen?
Neu registrieren
OpenAthens/Shibboleth Login
Warenkorb
Jahre (Archiv)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Ausgaben
Aktuelle Ausgabe
Kostenlose Probeausgabe (01/2024)
Ähnliche Zeitschriften
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Bücher zum Thema
Psychiatrie, Psychotherapie, Psychosomatik
25th Symposium of the AGNP
Abstracts (HTML)
Autorenliste
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
W
X
Y
Z
Wagner, E. M.
Functional Consequences of the accumulation of psychopharmacological drugs in „lipid rafts“ on ligand-gated ion channels
Wagner, K.
Olanzapine versus placebo in adolescent mania
Wagner, T.
Prediction of outcome by multimodal monitoring of treatment processes in alcoholism therapy
Wähner, A.
Levetiracetam and Disulfiram for relapse prevention in patients with alcohol dependence
Waldmeier, L.
Molecular circadian rhythms in humans: effects of age
Waldschmitt, C.
Serum concentrations of Duloxetine and Clinical Effects
Walitza, S.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Walser, S. M.
Conditional overexpression of corticotropin-releasing hormone – an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology
Walther, D.
Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
Wang, W. V.
Olanzapine versus placebo in adolescents with schizophrenia
Warnke, A.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Watz, D.
In-vivo topography of structural alterations of the anterior cingulate gyrus in schizophrenia
Weber, F.
Protein expression profiling of human glatiramer acetate (GA) and myelin basic protein (MBP) specific T cell lines from a multiple sclerosis (MS) patient and healthy donors
Weber, P.
Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment
Dissecting CRHR1-mediated pathways via microarray technology
Using viral vectors to study local gene function in the mouse brain
The role of tachykinin 1 in a mouse model of trait anxiety
Wedekind, D.
Factors Affecting the Pharmacokinetics of Escitalopram – Data from a Naturalistic Study
Wehrle, R.
Increased prevalence of restless legs syndrome in narcoleptic patients
Slow wave sleep and REM sleep awakenings do not affect sleep dependent memory consolidation
Metabolic and cardiovascular risk factors in narcolepsy
The effects of partial sleep deprivation on response inhibition studied by combined functional MRI and EEG
Daytime sleep after glucose intake in patients with narcolepsy
Control of the anterior cingulate/mPFC over the amygdala: a longitudinal fMRI study in patients with panic disorder
Weis, S.
Changes of CB1 cannabinoid receptor expression following Selective Serotonin Reuptake Inhibitors (SSRI) and First Generation Antipsychotics (FGA) in depression and bipolar disorder
Weiss, M. D.
Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder
Wendl, A.
Acromegalic patients: more depressed, without panic? The 'endocrine psychosyndrome' of acromegaly revised
Wenninger, S.
Aripiprazole has both agonistic and antagonistic effects on the dopaminergic system in endocrinological challenge tests
Werner, C.
Office-based post-marketing surveillance study on the influence of long term therapy with aripiprazole in patients with schizophrenia
Intramuscular Aripiprazole for the Treatment of Acute Agitation Associated with Schizophrenia: Sub-analysis of a Double-blind, Controlled, Dose-ranging Study
Postmarketing surveillance of aripiprazole in a hospital-based setting
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, placebo- and lithium-controlled study
Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar Disorder
Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Wester, M.
A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD
Wetter, T.
The effects of partial sleep deprivation on response inhibition studied by combined functional MRI and EEG
Wetter, T. C.
Cognitive functions in patients with restless legs syndrome
Increased prevalence of restless legs syndrome in narcoleptic patients
Metabolic and cardiovascular risk factors in narcolepsy
Daytime sleep after glucose intake in patients with narcolepsy
Successful treatment of tardive dyskinesia with botulinum toxin
Wichert, S. P.
Phase-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling syndrome
Widschwendter, C. G.
Drug attitude during the initial treatment period: A prospective follow-up study in patients with schizophrenia
Wiedeman, K.
Elevated alcohol consumption in mice lacking functional natriruetic peptide-A receptor
Wiedemann, K.
A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD
Wiesch, A.
Postmarketing surveillance of aripiprazole in a hospital-based setting
Wiethoff, K.
Evaluating algorithm-guided treatment for anxious depression in the German Algorithm Project (GAP)
Is the evaluation of early symptom decrease and serum drug levels predictive for response in depressed patients?
Wigger, A.
Expressing emotions: Avp and Crh are involved in the phenotype of mice bred for extremes in anxiety-related behavior
Wilens, T. E.
Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder
Wilk, K.
Effects of the NMDA receptor antagonist ketamine on stress hormone system regulation, cognitive functioning and posttraumatic stress symptomatology in accident victims
Williams, D. W.
Long-term, open-label safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: final report of a 4-year study
Wilms, S.
NMDA-hyposensitivity in whole blood platelets of amisulpride-treated schizophrenics
A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: Beyond seroprevalence
Wiltfang, J.
Decreases of hematopoietic stem cells in early Alzheimer's disease
A-beta peptide signatures in brains, CSF and blood plasma from APP23 transgenic mice
Winkelmann, J.
Cognitive functions in patients with restless legs syndrome
Winter, C.
Deep brain stimulation of the globus pallidus differentially affects compulsive checking behavior in rats
Modulation of subthalamic nucleus activity differentially affects compulsive behavior in rats
Deep brain stimulation of the nucleus accumbens core and shell differentially reduce quinpirole induced compulsive checking behavior in rats
Wirz-Justice, A.
Molecular circadian rhythms in humans: effects of age
Wittchen, H. U.
Specific vulnerability and risk factors for the onset of panic disorder, agoraphobia and other phobias
Maternal psychopathology – a risk factor for affective, anxiety and substance use disorders in offspring? Results from a prospective-longitudinal community study
Maternal psychopathology – a risk factor for affective, anxiety and substance use disorders in offspring? Results from a prospective-longitudinal community study
The interplay of familial depression liability and adverse life events in predicting the first onset of depression during a ten-year follow-up
Acromegalic patients: more depressed, without panic? The 'endocrine psychosyndrome' of acromegaly revised
Wittgens, W.
Treatment of affective Symptoms in Geriatric Psychiatry with Pregabalin
Wobrock, T.
5-HTTLPR polymorphism influences amygdala volume
Wochnik, G.
Differential effects of TPR proteins on steroid receptor signaling
Wochnik-Veltrup, G.
Proteomic search for intrcellular binding sites of antidepressants
Wöckel, L.
Reduced intracellular platelet Ca2+ responses to serotonin in patients with anorexia and bulimia nervosa increase under antidepressant medication
Wolferstätter, M.
Linking cognitive abilities and stress reactivity: insights from the HR/IR/LR mouse model
Wollweber, B. T.
Effect of Alcohol on Hypothalamus Neurons
Wood, W. G.
Vicious cycle in Alzheimer's disease: Amyloid beta aggravates its own production
Wotjak, C. T.
Characterization of dopamine release and metabolism in the prefrontal cortex of C57BL/6L and BALB/c mice
Endocannabinoid signaling modulates HPA axis activity in the mouse – implications for depression disorders
Conditional overexpression of corticotropin-releasing hormone – an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology
Using viral vectors to study local gene function in the mouse brain
Role of contextual fear memory in development of Posttraumatic Stress Disorder (PTSD)-like symptoms in mice
Wozniak, J.
Olanzapine versus placebo in adolescent mania
Wurst, W.
Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment
Generation of a CRH-Cre mouse line to analyze the CRH system
Dissecting CRHR1-mediated pathways via microarray technology
Conditional overexpression of corticotropin-releasing hormone – an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology